載入...
Upregulation of Glutamic-Oxaloacetic Transaminase 1 Predicts Poor Prognosis in Acute Myeloid Leukemia
One of the key features of acute myeloid leukemia (AML), a group of very aggressive myeloid malignancies, is their strikingly heterogenous outcomes. Accurate biomarkers are needed to improve prognostic assessment. Glutamate oxaloacetate transaminase 1 (GOT1) is essential for cell proliferation and a...
Na minha lista:
| 發表在: | Front Oncol |
|---|---|
| Main Authors: | , , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Frontiers Media S.A.
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7105742/ https://ncbi.nlm.nih.gov/pubmed/32266153 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2020.00379 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|